Steroids and the blood-brain barrier: Therapeutic implications

Advances in Pharmacology

Volumn 71, Issue , 2014, Pages 361-390

  Witt, Ken A ^a   Sandoval, Karin E ^a  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

Blood brain barrier; Estrogen; Glucocorticoid; Inflammation; Neurosteroids; Neurovascular unit; P glycoprotein; Steroid; Tight junction; Transport

Indexed keywords

ABC TRANSPORTER; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CLAUDIN 5; DEXAMETHASONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE TRANSPORTER 1; INTERCELLULAR ADHESION MOLECULE 1; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; NEUROSTEROID; OCCLUDIN; ORGANIC ANION TRANSPORTER; PRASTERONE SULFATE; PREGNANE X RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; STEROID;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIAL CELL; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG DEPENDENCE; DRUG TARGETING; DRUG UPTAKE; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EPILEPSY; ESTROGEN THERAPY; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; MEMBRANE TRANSPORT; MICROVASCULATURE; MULTIPLE SCLEROSIS; NEOVASCULARIZATION (PATHOLOGY); NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUTRIENT DYNAMICS; NUTRIENT UPTAKE; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL CIRCULATION; PHYSIOLOGICAL PROCESS; SCHIZOPHRENIA; TIGHT JUNCTION; TRANSCYTOSIS; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; ANIMAL; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; ESTROGENS; GLUCOCORTICOIDS; HUMANS;

EID: 84907998907     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2014.06.018     Document Type: Chapter

References (153)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiology of Disease 2010, 37:13-25.
2. Ardelt A.A., McCullough L.D., Korach K.S., Wang M.M., Munzenmaier D.H., Hurn P.D. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke 2005, 36:337-341.
3. Asaba H., Hosoya K., Takanaga H., Ohtsuki S., Tamura E., Takizawa T., et al. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. Journal of Neurochemistry 2000, 75:1907-1916.
4. Bake S., Sohrabji F. 17beta-Estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 2004, 145:5471-5475.
5. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiology of Disease 2010, 37:26-32.
6. Bauer B., Hartz A.M., Fricker G., Miller D.S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Molecular Pharmacology 2004, 66:413-419.
7. Bauer B., Yang X., Hartz A.M., Olson E.R., Zhao R., Kalvass J.C., et al. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Molecular Pharmacology 2006, 70:1212-1219.
8. Baulieu E.E. Neurosteroids: Of the nervous system, by the nervous system, for the nervous system. Recent Progress in Hormone Research 1997, 52:1-32.
9. Beauchamp K., Mutlak H., Smith W.R., Shohami E., Stahel P.F. Pharmacology of traumatic brain injury: Where is the "golden bullet"?. Molecular Medicine 2008, 14:731-740.
10. Birmingham M.K., Sar M., Stumpf W.E. Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochemical Research 1984, 9:333-350.
11. Blecharz K.G., Drenckhahn D., Forster C.Y. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. Journal of Cerebral Blood Flow and Metabolism 2008, 28:1139-1149.
12. Blecharz K.G., Haghikia A., Stasiolek M., Kruse N., Drenckhahn D., Gold R., et al. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Multiple Sclerosis 2010, 16:293-302.
13. Brinton R.D. Investigative models for determining hormone therapy-Induced outcomes in brain: Evidence in support of a healthy cell bias of estrogen action. Annals of the New York Academy of Sciences 2005, 1052:57-74.
14. Burek M., Arias-Loza P.A., Roewer N., Forster C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:298-304.
15. Burek M., Steinberg K., Forster C.Y. Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta. Molecular and Cellular Endocrinology 2014, 392(1-2):144-151.
16. Butt A.M., Jones H.C., Abbott N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study. The Journal of Physiology 1990, 429:47-62.
17. Chan G.N., Hoque M.T., Cummins C.L., Bendayan R. Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. Journal of Neurochemistry 2011, 118:163-175.
18. Chan G.N., Saldivia V., Yang Y., Pang H., de Lannoy I., Bendayan R. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: An intracerebral microdialysis study. Journal of Neurochemistry 2013, 127:342-352.
19. Chang E., O'Donnell M.E., Barakat A.I. Shear stress and 17beta-estradiol modulate cerebral microvascular endothelial Na-K-Cl cotransporter and Na/H exchanger protein levels. American Journal of Physiology. Cell Physiology 2008, 294:C363-C371.
20. Chang T.K., Waxman D.J. Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Drug Metabolism Reviews 2006, 38:51-73.
21. Chen J.Q., Eshete M., Alworth W.L., Yager J.D. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. Journal of Cellular Biochemistry 2004, 93:358-373.
22. Cheng C.M., Cohen M., Wang J., Bondy C.A. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. Faseb Journal 2001, 15:907-915.
23. Ciriaco M., Ventrice P., Russo G., Scicchitano M., Mazzitello G., Scicchitano F., et al. Corticosteroid-related central nervous system side effects. Journal of Pharmacology and Pharmacotherapeutics 2013, 4:S94-S98.
24. Cornford E.M., Nguyen E.V., Landaw E.M. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. American Journal of Physiology. Heart and Circulatory Physiology 2000, 279:H1346-H1354.
25. Cui J.Y., Gunewardena S.S., Rockwell C.E., Klaassen C.D. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Research 2010, 38:7943-7963.
26. Dahlin A., Royall J., Hohmann J.G., Wang J. Expression profiling of the solute carrier gene family in the mouse brain. The Journal of Pharmacology and Experimental Therapeutics 2009, 329:558-570.
27. Dietrich J. Glucocorticoid hormones and estrogens: Their interaction with the endothelial cells of the blood-brain barrier. Blood-brain interfaces: From ontogeny to artificial barriers 2006, Vol. 1:287-312. Wiley, Weinheim, Germany. R. Dermietzel, D.C. Spray, M. Nedergaard (Eds.).
28. Dietrich J., Rao K., Pastorino S., Kesari S. Corticosteroids in brain cancer patients: Benefits and pitfalls. Expert Review of Clinical Pharmacology 2011, 4:233-242.
29. Dodel R.C., Du Y., Bales K.R., Gao F., Paul S.M. Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides. Journal of Neurochemistry 1999, 73:1453-1460.
30. Droste S.K., de Groote L., Atkinson H.C., Lightman S.L., Reul J.M., Linthorst A.C. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008, 149:3244-3253.
31. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., et al. Estradiol protects against ischemic injury. Journal of Cerebral Blood Flow and Metabolism 1998, 18:1253-1258.
32. Emami Riedmaier A., Nies A.T., Schaeffeler E., Schwab M. Organic anion transporters and their implications in pharmacotherapy. Pharmacological Reviews 2012, 64:421-449.
33. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2959-2968.
34. Evans P.D., Bayliss A., Reale V. GPCR-mediated rapid, non-genomic actions of steroids: Comparisons between DmDopEcR and GPER1 (GPR30). General and Comparative Endocrinology 2014, 195:157-163.
35. Feldman G.J., Mullin J.M., Ryan M.P. Occludin: Structure, function and regulation. Advanced Drug Delivery Reviews 2005, 57:883-917.
36. Felinski E.A., Cox A.E., Phillips B.E., Antonetti D.A. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Experimental Eye Research 2008, 86:867-878.
37. Forster C., Burek M., Romero I.A., Weksler B., Couraud P.O., Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. The Journal of Physiology 2008, 586:1937-1949.
38. Forster C., Kahles T., Kietz S., Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. The Journal of Physiology 2007, 580:937-949.
39. Forster C., Silwedel C., Golenhofen N., Burek M., Kietz S., Mankertz J., et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. The Journal of Physiology 2005, 565:475-486.
40. Galea E., Santizo R., Feinstein D.L., Adamsom P., Greenwood J., Koenig H.M., et al. Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation. Neuroreport 2002, 13:1469-1472.
41. Galicich J.H., French L.A., Melby J.C. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. The Journal-Lancet 1961, 81:46-53.
42. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. The Journal of Biological Chemistry 2001, 276:14581-14587.
43. Gelati M., Corsini E., Dufour A., Massa G., Giombini S., Solero C.L., et al. High-dose methylprednisolone reduces cytokine-induced adhesion molecules on human brain endothelium. The Canadian Journal of Neurological Sciences 2000, 27:241-244.
44. Giannotta M., Trani M., Dejana E. VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Developmental Cell 2013, 26:441-454.
45. Giatti S., Boraso M., Melcangi R.C., Viviani B. Neuroactive steroids, their metabolites, and neuroinflammation. Journal of Molecular Endocrinology 2012, 49:R125-R134.
46. Gonzales R.J. Androgens and the cerebrovasculature: Modulation of vascular function during normal and pathophysiological conditions. Pflügers Archiv 2013, 465:627-642.
47. Gonzales R.J., Duckles S.P., Krause D.N. Dihydrotestosterone stimulates cerebrovascular inflammation through NFkappaB, modulating contractile function. Journal of Cerebral Blood Flow and Metabolism 2009, 29:244-253.
48. Guo J., Krause D.N., Horne J., Weiss J.H., Li X., Duckles S.P. Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. Journal of Cerebral Blood Flow and Metabolism 2010, 30:545-554.
49. Harhaj N.S., Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. The International Journal of Biochemistry & Cell Biology 2004, 36:1206-1237.
50. Harkness K.A., Sussman J.D., Davies-Jones G.A., Greenwood J., Woodroofe M.N. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. Journal of Neuroimmunology 2003, 142:1-9.
51. Hartmann C., El-Gindi J., Lohmann C., Lischper M., Zeni P., Galla H.J. TIMP-3: A novel target for glucocorticoid signaling at the blood-brain barrier. Biochemical and Biophysical Research Communications 2009, 390:182-186.
52. Hartz A.M., Madole E.K., Miller D.S., Bauer B. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. The Journal of Pharmacology and Experimental Therapeutics 2010, 334:467-476.
53. Hartz A.M., Mahringer A., Miller D.S., Bauer B. 17-beta-Estradiol: A powerful modulator of blood-brain barrier BCRP activity. Journal of Cerebral Blood Flow and Metabolism 2010, 30:1742-1755.
54. Heiss J.D., Papavassiliou E., Merrill M.J., Nieman L., Knightly J.J., Walbridge S., et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. The Journal of Clinical Investigation 1996, 98:1400-1408.
55. Holm A., Baldetorp B., Olde B., Leeb-Lundberg L.M., Nilsson B.O. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. Journal of Vascular Research 2011, 48:327-335.
56. Honda M., Nakagawa S., Hayashi K., Kitagawa N., Tsutsumi K., Nagata I., et al. Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5. Cellular and Molecular Neurobiology 2006, 26:108-118.
57. Howard B.V., Rossouw J.E. Estrogens and cardiovascular disease risk revisited: The Women's Health Initiative. Current Opinion in Lipidology 2013, 24:493-499.
58. Huber J.D., Campos C.R., Mark K.S., Davis T.P. Alterations in blood-Brain barrier ICAM-1 expression and brain microglial activation following {lambda}-carrageenan induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology 2005, 290(2):H732-H740.
59. Iqbal M., Gibb W., Matthews S.G. Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier. Endocrinology 2011, 152:1067-1079.
60. Jesmin S., Hattori Y., Sakuma I., Liu M.Y., Mowa C.N., Kitabatake A. Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. Journal of Cerebral Blood Flow and Metabolism 2003, 23:181-189.
61. Joels M., Sarabdjitsingh R.A., Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: Rapid, slow, and chronic modes. Pharmacological Reviews 2012, 64:901-938.
62. Johann S., Beyer C. Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. The Journal of Steroid Biochemistry and Molecular Biology 2013, 137:71-81.
63. Johnson A.B., Sohrabji F. Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiology of Aging 2005, 26:1365-1374.
64. Kancheva R., Hill M., Novak Z., Chrastina J., Kancheva L., Starka L. Neuroactive steroids in periphery and cerebrospinal fluid. Neuroscience 2011, 191:22-27.
65. Kang H.S., Ahn H.S., Kang H.J., Gye M.C. Effect of estrogen on the expression of occludin in ovariectomized mouse brain. Neuroscience Letters 2006, 402:30-34.
66. Karssen A.M., Meijer O.C., van der Sandt I.C., Lucassen P.J., de Lange E.C., de Boer A.G., et al. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001, 142:2686-2694.
67. Kashiwamura Y., Sano Y., Abe M., Shimizu F., Haruki H., Maeda T., et al. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochemical Research 2011, 36:849-855.
68. Keil J.M., Liu X., Antonetti D.A. Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO. Investigative Ophthalmology & Visual Science 2013, 54:4007-4015.
69. Kim H., Lee J.M., Park J.S., Jo S.A., Kim Y.O., Kim C.W., et al. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: A mechanism of glucocorticoid-Induced stabilization of blood-Brain barrier. Biochemical and Biophysical Research Communications 2008, 372:243-248.
70. Koehler R.C., Gebremedhin D., Harder D.R. Role of astrocytes in cerebrovascular regulation. Journal of Applied Physiology 2006, 100:307-317.
71. Leon R.L., Li X., Huber J.D., Rosen C.L. Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17beta-estradiol. Endocrinology 2012, 153:3386-3393.
72. Lewis D.K., Johnson A.B., Stohlgren S., Harms A., Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. Journal of Neuroimmunology 2008, 195:47-59.
73. Leybaert L. Neurobarrier coupling in the brain: A partner of neurovascular and neurometabolic coupling?. Journal of Cerebral Blood Flow and Metabolism 2005, 25:2-16.
74. Liu Y., Liu F., Iqbal K., Grundke-Iqbal I., Gong C.X. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Letters 2008, 582:359-364.
75. Liu Y., Nusrat A., Schnell F.J., Reaves T.A., Walsh S., Pochet M., et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. Journal of Cell Science 2000, 113(Pt 13):2363-2374.
76. Liu R., Wen Y., Perez E., Wang X., Day A.L., Simpkins J.W., et al. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-Reperfusion injury in female rats. Brain Research 2005, 1060:55-61.
77. Luchetti S., Huitinga I., Swaab D.F. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 2011, 191:6-21.
78. Mahringer A., Fricker G. BCRP at the blood-brain barrier: Genomic regulation by 17beta-estradiol. Molecular Pharmaceutics 2010, 7:1835-1847.
79. Mandell K.J., McCall I.C., Parkos C.A. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. The Journal of Biological Chemistry 2004, 279:16254-16262.
80. Meijer O.C., de Lange E.C., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139:1789-1793.
81. Melcangi R.C., Panzica G.C. Neuroactive steroids and the nervous system: Further observations on an incomplete tricky puzzle. Journal of Neuroendocrinology 2013, 25:957-963.
82. Melcangi R.C., Panzica G., Garcia-Segura L.M. Neuroactive steroids: Focus on human brain. Neuroscience 2011, 191:1-5.
83. Miller D.S., Cannon R.E. Signaling pathways that regulate basal ABC transporter activity at the blood-Brain barrier. Current Pharmaceutical Design 2013, 20(10):1463-1471.
84. Mirshafiey A., Asghari B., Ghalamfarsa G., Jadidi-Niaragh F., Azizi G. The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis. Sultan Qaboos University Medical Journal 2014, 14:e13-e25.
85. Miyajima M., Kusuhara H., Fujishima M., Adachi Y., Sugiyama Y. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice. Drug Metabolism and Disposition 2011, 39:814-819.
86. Mori M., Tsukahara F., Yoshioka T., Irie K., Ohta H. Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sciences 2004, 75:599-609.
87. Murata T., Dietrich H.H., Xiang C., Dacey R.G. G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats. Stroke 2013, 44:779-785.
88. Nakano M., Hirooka Y., Matsukawa R., Ito K., Sunagawa K. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Hypertension Research 2013, 36:277-284.
89. Narang V.S., Fraga C., Kumar N., Shen J., Throm S., Stewart C.F., et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. American Journal of Physiology. Cell Physiology 2008, 295:C440-C450.
90. Nobili S., Landini I., Mazzei T., Mini E. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Medicinal Research Reviews 2012, 32:1220-1262.
91. Noguchi K., Katayama K., Sugimoto Y. Human ABC transporter ABCG2/BCRP expression in chemoresistance: Basic and clinical perspectives for molecular cancer therapeutics. Pharmacogenomics and Personalised Medicine 2014, 7:53-64.
92. Nordell V.L., Scarborough M.M., Buchanan A.K., Sohrabji F. Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiology of Aging 2003, 24:733-743.
93. Norris J.W. Steroids may have a role in stroke therapy. Stroke 2004, 35:228-229.
94. O'Donnell M.E., Lam T.I., Tran L.Q., Foroutan S., Anderson S.E. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism 2006, 26(10):1234-1249.
95. Ohtsuki S., Tomi M., Hata T., Nagai Y., Hori S., Mori S., et al. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers. Journal of Cellular Physiology 2005, 204:896-900.
96. Oki K., Gomez-Sanchez E.P., Gomez-Sanchez C.E. Role of mineralocorticoid action in the brain in salt-sensitive hypertension. Clinical and Experimental Pharmacology & Physiology 2012, 39:90-95.
97. Oldendorf W.H., Cornford M.E., Brown W.J. The large apparent work capability of the blood-brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Annals of Neurology 1977, 1:409-417.
98. Ouyang S., Hsuchou H., Kastin A.J., Wang Y., Yu C., Pan W. Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism 2014, 34:43-51.
99. Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke: A prospective study. BMJ 1988, 297:519-522.
100. Pajouhesh H., Lenz G.R. Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2005, 2:541-553.
101. Papadopoulos M.C., Saadoun S., Binder D.K., Manley G.T., Krishna S., Verkman A.S. Molecular mechanisms of brain tumor edema. Neuroscience 2004, 129:1011-1020.
102. Petropoulos S., Gibb W., Matthews S.G. Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation. Brain Research 2010, 1357:9-18.
103. Piontek J., Winkler L., Wolburg H., Muller S.L., Zuleger N., Piehl C., et al. Formation of tight junction: Determinants of homophilic interaction between classic claudins. Faseb Journal 2008, 22:146-158.
104. Poetker D.M., Reh D.D. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngologic Clinics of North America 2010, 43:753-768.
105. Poungvarin N. Steroids have no role in stroke therapy. Stroke 2004, 35:229-230.
106. Prossnitz E.R., Barton M. Estrogen biology: New insights into GPER function and clinical opportunities. Molecular and Cellular Endocrinology 2014, 389(1-2):71-83.
107. Proteau P.J. Steroid hormones and therapeutically related compounds. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry 2011, 819-867. Wolters Kluwer, Lippincott Williams, Baltimore, MD. 12th ed. J.M. Beale, J.H. Block (Eds.).
108. Quillinan N., Deng G., Grewal H., Herson P.S. Androgens and stroke: Good, bad or indifferent?. Experimental Neurology 2014, S0014-4886(14):39-49.
109. Razmara A., Sunday L., Stirone C., Wang X.B., Krause D.N., Duckles S.P., et al. Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. The Journal of Pharmacology and Experimental Therapeutics 2008, 325:782-790.
110. Reddy D.S. Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Progress in Brain Research 2010, 186:113-137.
111. Resnick S.M., Coker L.H., Maki P.M., Rapp S.R., Espeland M.A., Shumaker S.A. The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clinical Trials 2004, 1:440-450.
112. Rettberg J.R., Yao J., Brinton R.D. Estrogen: A master regulator of bioenergetic systems in the brain and body. Frontiers in Neuroendocrinology 2014, 35:8-30.
113. Roberts T.K., Eugenin E.A., Lopez L., Romero I.A., Weksler B.B., Couraud P.O., et al. CCL2 disrupts the adherens junction: Implications for neuroinflammation. Laboratory Investigation 2012, 92:1213-1233.
114. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): Randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
115. Rutkowsky J.M., Wallace B.K., Wise P.M., O'Donnell M.E. Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance. American Journal of Physiology. Cell Physiology 2011, 301:C204-C212.
116. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., Furuse M., et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. The Journal of Cell Biology 1998, 141:397-408.
117. Sajja R.K., Prasad S., Cucullo L. Impact of altered glycaemia on blood-Brain barrier endothelium: An in vitro study using the hCMEC/D3 cell line. Fluids and Barriers of the CNS 2014, 11:8.
118. Salvador E., Shityakov S., Forster C. Glucocorticoids and endothelial cell barrier function. Cell and Tissue Research 2013, 355(3):597-605.
119. Sandoval K.E., Witt K.A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiology of Disease 2008, 32:200-219.
120. Sandoval K.E., Witt K.A. Age and 17beta-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvascular Research 2011, 81:198-205.
121. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., et al. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. Journal of the American Geriatrics Society 1996, 44:1307-1313.
122. Schultz S.K., O'Leary D.S., Boles Ponto L.L., Watkins G.L., Hichwa R.D., Andreasen N.C. Age-related changes in regional cerebral blood flow among young to mid-life adults. Neuroreport 1999, 10:2493-2496.
123. Schumacher M., Mattern C., Ghoumari A., Oudinet J.P., Liere P., Labombarda F., et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors. Progress in Neurobiology 2014, 113:6-39.
124. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Progress in Neurobiology 2003, 71:3-29.
125. Selvamani A., Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiology of Aging 2010, 31:1618-1628.
126. Shi J., Simpkins J.W. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. The American Journal of Physiology 1997, 272:E1016-E1022.
127. Shi J., Zhang Y.Q., Simpkins J.W. Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Experimental Brain Research 1997, 117:200-206.
128. Simpson I.A., Davies P. Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease. Annals of Neurology 1994, 36:800-801.
129. Sohrabji F., Bake S., Lewis D.K. Age-related changes in brain support cells: Implications for stroke severity. Neurochemistry International 2013, 63:291-301.
130. Song L., Pachter J.S. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvascular Research 2004, 67:78-89.
131. Spence R.D., Voskuhl R.R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Frontiers in Neuroendocrinology 2012, 33:105-115.
132. Stamatovic S.M., Shakui P., Keep R.F., Moore B.B., Kunkel S.L., Van Rooijen N., et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. Journal of Cerebral Blood Flow and Metabolism 2005, 25:593-606.
133. Stirone C., Duckles S.P., Krause D.N. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: Regulation by estrogen. American Journal of Physiology. Endocrinology and Metabolism 2003, 284:E184-E192.
134. Su C., Rybalchenko N., Schreihofer D.A., Singh M., Abbassi B., Cunningham R.L. Cell models for the study of sex steroid hormone neurobiology. Journal of Steroids & Hormonal Science 2012, Suppl 2:003.
135. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nature Cell Biology 2008, 10:923-934.
136. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Medicine 2000, 6:460-463.
137. Tu J., Jufri N.F. Estrogen signaling through estrogen receptor beta and G-protein-coupled estrogen receptor 1 in human cerebral vascular endothelial cells: Implications for cerebral aneurysms. BioMed Research International 2013, 2013:524324.
138. Valable S., Montaner J., Bellail A., Berezowski V., Brillault J., Cecchelli R., et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: Both effects decreased by Ang-1. Journal of Cerebral Blood Flow and Metabolism 2005, 25:1491-1504.
139. Vest R.S., Pike C.J. Gender, sex steroid hormones, and Alzheimer's disease. Hormones and Behavior 2013, 63:301-307.
140. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. The New England Journal of Medicine 2001, 345:1243-1249.
141. Wang W., Dentler W.L., Borchardt R.T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. American Journal of Physiology Heart and Circulatory Physiology 2001, 280:H434-H440.
142. Wang X., Zhang J., Yang Y., Dong W., Wang F., Wang L., et al. Progesterone attenuates cerebral edema in neonatal rats with hypoxic-Ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4. Experimental and Therapeutic Medicine 2013, 6:263-267.
143. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 2003, 289:2673-2684.
144. Weber C., Fraemohs L., Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nature Reviews Immunology 2007, 7:467-477.
145. Wierman M.E. Sex steroid effects at target tissues: Mechanisms of action. Advances in Physiology Education 2007, 31:26-33.
146. Won S., Lee J.H., Wali B., Stein D.G., Sayeed I. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: Involvement of the VEGF-MMP pathway. Journal of Cerebral Blood Flow and Metabolism 2014, 34:72-80.
147. Yang S.H., Liu R., Wu S.S., Simpkins J.W. The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Annals of the New York Academy of Sciences 2003, 1007:101-107.
148. Yang Y., Rosenberg G.A. MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods in Molecular Biology 2011, 762:333-345.
149. Yao Y., Tsirka S.E. Monocyte chemoattractant protein-1 and the blood-Brain barrier. Cellular and Molecular Life Sciences 2014, 71:683-697.
150. Ye L., Martin T.A., Parr C., Harrison G.M., Mansel R.E., Jiang W.G. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. Journal of Cellular Physiology 2003, 196:362-369.
151. Zhang Z., Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends in Cardiovascular Medicine 2002, 12:62-66.
152. Ziylan Y.Z., LeFauconnier J.M., Bernard G., Bourre J.M. Effect of dexamethasone on transport of alpha-Aminoisobutyric acid and sucrose across the blood-Brain barrier. Journal of Neurochemistry 1988, 51:1338-1342.
153. Ziylan Y.Z., Lefauconnier J.M., Bernard G., Bourre J.M. Regional alterations in blood-to-brain transfer of alpha-aminoisobutyric acid and sucrose, after chronic administration and withdrawal of dexamethasone. Journal of Neurochemistry 1989, 52:684-689.